NRI from all over the world (including U.S.A. & Canada) can invest in this fund
SBNRI is a certified Mutual Fund distributor registered with Association of Mutual Funds in India (AMFI) with Reg. No. 246671
₹516.87
-0.21%
NAV as on 08 Dec 24, 12:00 AM
very high risk
sector healthcare
equity
NAV as on 08 Dec 24, 12:00 AM
very high risk
sector healthcare
equity
37.41%p.a.
Last 1Y
20.70%p.a.
Last 3Y
28.00%p.a.
Last 5Y
21.17%p.a.
Since Inception
NRIs can achieve long-term capital appreciation by investing in the Nippon India Pharma Fund - Growth scheme from Nippon Life India Asset Management Ltd. It is a Sector - Healthcare mutual fund scheme that predominantly invests in Sector - Healthcare stocks of companies. Launched on Jun 2004, Nippon India Pharma Fund - Growth is Sector - Healthcare fund of its category with 8,638.23 Cr fund under management as on Dec 2024. The expense ratio of this fund is less than that of most other Fund category Sector - Healthcare funds.
The primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related or fixed income securities of Pharma and other associated companies.
Sun Pharmaceuticals Industries Ltd
13.52%
Divi's Laboratories Ltd
9.65%
Lupin Ltd
7.61%
Cipla Ltd
5.50%
Apollo Hospitals Enterprise Ltd
5.13%
Dr Reddy's Laboratories Ltd
5.10%
Vijaya Diagnostic Centre Ltd
4.09%
Ajanta Pharma Ltd
3.36%
Medplus Health Services Ltd
3.23%
Gland Pharma Ltd
3.02%
View Scheme Document
If invested
per month
For a period of
Investment of ₹0 could have been
₹0(+0.0%)
₹0 (+0.0%)
This Fund
₹0 (+0.0%)
Fixed Deposit
Just like for resident investors, capital gains from mutual fund investments are subject to income tax for NRI investors.
Fund Type | Short-term Capital Gains (STCG) Tax | Long-term Capital Gains (LTCG) Tax |
---|---|---|
Equity mutual funds | 15% | 10% (above Rs. 1 lakh LTCG) without indexation* |
Debt & other types of funds | At tax slab rate | 20% with indexation benefits |
NRIs and OCIs can download the SBNRI app to invest in mutual funds from the country of their residence. Here are a few simple steps you need to take:
If all details are correct, your KYC will be approved within 7 to 8 business days.
Funds
3Y Return
very high risk | equity
25.6%
very high risk | equity
25.5%
very high risk | equity
23.3%